macgene 发表于 2009-1-5 09:55:00

[原创]逆转录病毒感染试剂盒

<span style="FONT-SIZE: 16pt; FONT-FAMILY: 宋体; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA;"><strong><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><span><font face="Times New Roman">Retroviral Infection Kit</font>逆转录病毒感染试剂盒<p></p></span></p><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><font size="3"><span lang="IT" style="mso-ansi-language: IT;"><font face="Times New Roman">Catalogue</font></span><span style="FONT-FAMILY: 宋体; mso-ascii-font-family: &quot;Times New Roman&quot;; mso-hansi-font-family: &quot;Times New Roman&quot;; mso-ansi-language: IT;">:</span><span lang="IT" style="mso-ansi-language: IT;"><font face="Times New Roman">CTK002<span style="mso-spacerun: yes;">&nbsp; </span>Storage: 4</font></span><span style="FONT-FAMILY: 宋体; mso-ascii-font-family: &quot;Times New Roman&quot;; mso-hansi-font-family: &quot;Times New Roman&quot;; mso-ansi-language: IT;">-</span><font face="Times New Roman"><span>8 &ordm;C<p></p></span></font></font></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><i style="mso-bidi-font-style: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Kit components:<p></p></span></i></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p><table class="MsoTableGrid" cellspacing="0" cellpadding="0" border="0" style="BORDER-COLLAPSE: collapse; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-yfti-tbllook: 480;"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes;"><td valign="top" width="108" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><b style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Components<p></p></span></b></p></td><td valign="top" width="136" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 102.05pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><b style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Name<p></p></span></b></p></td><td valign="top" width="109" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81.55pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><b style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Size<p></p></span></b></p></td></tr><tr style="mso-yfti-irow: 1;"><td valign="top" width="108" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">A<p></p></span></p></td><td valign="top" width="136" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 102.05pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">HBS<p></p></span></p></td><td valign="top" width="109" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81.55pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">100mL<p></p></span></p></td></tr><tr style="mso-yfti-irow: 2;"><td valign="top" width="108" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">B<p></p></span></p></td><td valign="top" width="136" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 102.05pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">CaCl<sub>2</sub><p></p></span></p></td><td valign="top" width="109" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81.55pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">10mL<p></p></span></p></td></tr><tr style="mso-yfti-irow: 3;"><td valign="top" width="108" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">C<p></p></span></p></td><td valign="top" width="136" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 102.05pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Helper<p></p></span></p></td><td valign="top" width="109" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81.55pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">20ug in 20uL<p></p></span></p></td></tr><tr style="mso-yfti-irow: 4;"><td valign="top" width="108" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">D<p></p></span></p></td><td valign="top" width="136" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 102.05pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">pMac-vGFP<p></p></span></p></td><td valign="top" width="109" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81.55pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">20ug in 20uL<p></p></span></p></td></tr><tr style="mso-yfti-irow: 5; mso-yfti-lastrow: yes;"><td valign="top" width="108" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" align="center" style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">E<p></p></span></p></td><td valign="top" width="136" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 102.05pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Polybrene<p></p></span></p></td><td valign="top" width="109" style="BORDER-RIGHT: #ece9d8; PADDING-RIGHT: 5.4pt; BORDER-TOP: #ece9d8; PADDING-LEFT: 5.4pt; PADDING-BOTTOM: 0cm; BORDER-LEFT: #ece9d8; WIDTH: 81.55pt; PADDING-TOP: 0cm; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">1mL<p></p></span></p></td></tr></tbody></table></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><i style="mso-bidi-font-style: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Principle:<p></p></span></i></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">The MSCV (Murine Stem Cell Virus) Retroviral Expression System contains vectors that are optimized for introducing and expressing target genes in proliferating murine or human cell lines. This highly efficient system is ideal for analyzing gene expression and function in development, embryogenesis, and carcinogenesis in both cell culture and transgenic assays.<p></p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Designed for tough-to-transfect cells, the MSCV system contains two vectors: pMac-vGFP and helper that expresses protein elements required for producing high-titer virus. These vectors contain a specially designed long terminal repeat (LTR) from the murine stem cell virus that allows you to transduce most hard-to-transfect cell lines. This system drives high-level, constitutive expression of the target gene in most mammalian cell lines. <p></p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><shapetype id="_x0000_t202" path="m,l,21600r21600,l21600,xe" ospt="202" coordsize="21600,21600"><stroke joinstyle="miter"></stroke><path oconnecttype="rect" gradientshapeok="t"></path></shapetype><shape id="_x0000_s1026" stroked="f" type="#_x0000_t202" style="MARGIN-TOP: 2.55pt; Z-INDEX: 1; LEFT: 0px; MARGIN-LEFT: 404.85pt; WIDTH: 134.4pt; POSITION: absolute; HEIGHT: 217.2pt; TEXT-ALIGN: left; mso-wrap-style: none;"><textbox style="mso-fit-shape-to-text: t;"><table cellspacing="0" cellpadding="0" width="100%"><tbody><tr><td style="BORDER-RIGHT: #ece9d8; BORDER-TOP: #ece9d8; BORDER-LEFT: #ece9d8; BORDER-BOTTOM: #ece9d8; BACKGROUND-COLOR: transparent;"><div><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US"><shapetype id="_x0000_t75" path="m@4@5l@4@11@9@11@9@5xe" ospt="75" coordsize="21600,21600" stroked="f" filled="f" opreferrelative="t"><stroke joinstyle="miter"></stroke><formulas><f eqn="if lineDrawn pixelLineWidth 0"></f><f eqn="sum @0 1 0"></f><f eqn="sum 0 0 @1"></f><f eqn="prod @2 1 2"></f><f eqn="prod @3 21600 pixelWidth"></f><f eqn="prod @3 21600 pixelHeight"></f><f eqn="sum @0 0 1"></f><f eqn="prod @6 1 2"></f><f eqn="prod @7 21600 pixelWidth"></f><f eqn="sum @8 21600 0"></f><f eqn="prod @7 21600 pixelHeight"></f><f eqn="sum @10 21600 0"></f></formulas><path oconnecttype="rect" gradientshapeok="t" oextrusionok="f"></path><lock aspectratio="t" vext="edit"></lock></shapetype><shape id="_x0000_i1025" type="#_x0000_t75" style="WIDTH: 120pt; HEIGHT: 201.75pt;"><imagedata otitle="" src="file:///C:\DOCUME~1\MACGEN~1\LOCALS~1\Temp\msohtml1\01\clip_image001.emz"></imagedata></shape></span></p></div></td></tr></tbody></table></textbox><wrap type="square"></wrap></shape><i style="mso-bidi-font-style: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Procedure:<p></p></span></i></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><i style="mso-bidi-font-style: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Step 1. Production of high-titer virus in 293 cells<p></p></span></i></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" align="left" style="MARGIN: 0cm 0cm 0pt 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: left; mso-pagination: widow-orphan; mso-list: l0 level1 lfo1; tab-stops: list 18.0pt left 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana; mso-fareast-font-family: Verdana; mso-bidi-font-family: Verdana;"><span style="mso-list: Ignore;">1.<span style="FONT: 7pt &quot;Times New Roman&quot;;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><i style="mso-bidi-font-style: normal;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Step 2. Infection of targeting cells<p></p></span></i></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">edr<p></p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt; tab-stops: 303.75pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;"><p>&nbsp;</p></span></p><p class="MsoNormal" style="MARGIN: 0cm 0cm 0pt;"><span lang="EN-US" style="FONT-SIZE: 9pt; FONT-FAMILY: Verdana;">Procedure illustration:</span></p><p></p></strong></span>

macgene 发表于 2009-1-5 09:56:00

<p><span style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体;">迈晨科技(北京)有限公司竭诚为您服务 !<span lang="EN-US"><p></p></span></span></p><p><span style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体;">详情请登录网站:<span lang="EN-US">www.macgene.com</span>,联系电话:<span lang="EN-US">010-82057786<p></p></span></span></p>

macgene 发表于 2009-3-30 12:30:44

迈晨科技(北京)有限公司竭诚为您服务 !



详情请登录网站:www.macgene.com,联系电话:010-82057786
页: [1]
查看完整版本: [原创]逆转录病毒感染试剂盒